Best TWAS P=5.35e-83 · Best GWAS P=1.79e-69 conditioned to 0.00143
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | CommonMind | Brain Pre-frontal Cortex | ESR1 | 0.19 | 0.10 | enet | 36 | 0.10 | 2.2e-12 | 11.5 | -8.9 | 5.8e-19 | -0.03 | 1.00 | 0.00 | TRUE |
2 | METSIM | Adipose | CCDC170 | 0.14 | 0.02 | blup | 621 | 0.07 | 6.1e-11 | -2.0 | -9.3 | 1.2e-20 | 0.35 | 0.99 | 0.00 | TRUE |
3 | ROSMAP | Brain Pre-frontal Cortex | CCDC170 | 0.20 | 0.06 | lasso | 10 | 0.19 | 7.2e-24 | -5.3 | -5.2 | 2.2e-07 | 0.53 | 0.11 | 0.89 | FALSE |
4 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | C6orf97 | 0.05 | 0.00 | blup | 133 | 0.03 | 1.3e-03 | -17.6 | -17.5 | 1.3e-68 | 0.80 | 0.01 | 0.87 | TRUE |
5 | The Cancer Genome Atlas | Breast Invasive Carcinoma | C6orf97 | 0.01 | 0.01 | enet | 7 | 0.01 | 5.3e-03 | -8.8 | -16.7 | 2.4e-62 | 0.82 | 0.01 | 0.94 | TRUE |
6 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | C6orf97 | 0.08 | 0.02 | blup | 133 | 0.07 | 6.2e-08 | -9.5 | -13.2 | 7.6e-40 | 0.68 | 0.02 | 0.98 | TRUE |
7 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | C6orf97 | 0.06 | 0.05 | lasso | 3 | 0.08 | 6.9e-09 | -10.4 | -12.4 | 2.3e-35 | 0.58 | 0.22 | 0.76 | FALSE |
8 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | C6orf97 | 0.18 | 0.06 | lasso | 4 | 0.05 | 1.1e-03 | -5.3 | -6.8 | 8.4e-12 | 0.49 | 0.33 | 0.32 | FALSE |
9 | The Cancer Genome Atlas | Brain Lower Grade Glioma | C6orf97 | 0.08 | 0.04 | blup | 133 | 0.09 | 1.2e-10 | -17.6 | -14.8 | 9.1e-50 | 0.78 | 0.00 | 1.00 | FALSE |
10 | The Cancer Genome Atlas | Lung Adenocarcinoma | C6orf97 | 0.07 | 0.03 | lasso | 5 | 0.05 | 1.7e-06 | -5.3 | -12.2 | 2.3e-34 | 0.71 | 0.01 | 0.97 | FALSE |
11 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | C6orf97 | 0.14 | 0.01 | blup | 133 | 0.08 | 5.2e-06 | -17.6 | -12.2 | 3.2e-34 | 0.74 | 0.00 | 0.94 | FALSE |
12 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | C6orf97 | 0.23 | 0.10 | lasso | 11 | 0.11 | 1.8e-05 | -17.6 | -19.3 | 5.3e-83 | 0.87 | 0.00 | 0.99 | TRUE |
13 | The Cancer Genome Atlas | Prostate Adenocarcinoma | C6orf97 | 0.10 | 0.05 | blup | 133 | 0.06 | 2.6e-07 | -17.6 | -10.6 | 4.9e-26 | 0.72 | 0.00 | 1.00 | TRUE |
14 | The Cancer Genome Atlas | Stomach Adenocarcinoma | C6orf97 | 0.13 | 0.02 | blup | 133 | 0.05 | 2.8e-04 | -9.5 | -11.4 | 3.1e-30 | 0.63 | 0.01 | 0.90 | TRUE |
15 | The Cancer Genome Atlas | Testicular Germ Cell Tumors | RMND1 | 0.19 | 0.06 | blup | 58 | 0.10 | 1.6e-04 | -4.2 | 5.6 | 2.2e-08 | 0.10 | 0.14 | 0.20 | FALSE |
16 | The Cancer Genome Atlas | Thyroid Carcinoma | C6orf97 | 0.08 | 0.02 | lasso | 4 | 0.06 | 3.4e-06 | -16.5 | -14.7 | 8.7e-49 | 0.85 | 0.01 | 0.98 | TRUE |